Summary
UnitedHealthcare Community Plan of Kentucky revised its FcRn Blockers medical benefit drug policy, effective 2027-01-01, to state that Imaavy is proven and medically necessary for warm autoimmune hemolytic anemia (wAIHA) in adults and children 12 and older currently or previously treated with corticosteroids, subject to specified diagnostic, treatment-history, dosing and prescriber criteria. ICD-10 code D59.11 was added to the applicable codes, and the policy covers Imaavy, Rystiggo, Vyvgart and Vyvgart Hytrulo vial for administration by a healthcare professional.
Get alerts when payers change rules like this one
We check UnitedHealthcare and other payers every day and email you when a change matches your specialty and state.